Lindbrook Capital’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$33.7K Buy
3,558
+1,516
+74% +$15.3K ﹤0.01% 1142
2024
Q4
$23K Sell
2,042
-258
-11% -$4.53K ﹤0.01% 1208
2024
Q3
$65K Buy
2,300
+46
+2% +$1.19K 0.01% 705
2024
Q2
$43.1K Sell
2,254
-84
-4% -$2.15K ﹤0.01% 856
2024
Q1
$76.7K Hold
2,338
0.01% 626
2023
Q4
$77.2K Sell
2,338
-26
-1% -$736 0.01% 599
2023
Q3
$64.4K Sell
2,364
-165
-7% -$4.59K 0.01% 598
2023
Q2
$76.6K Sell
2,529
-45
-2% -$1.46K 0.01% 565
2023
Q1
$83.5K Sell
2,574
-341
-12% -$10.8K 0.01% 532
2022
Q4
$81.9K Sell
2,915
-408
-12% -$11.7K 0.01% 543
2022
Q3
$119K Sell
3,323
-224
-6% -$7.89K 0.02% 397
2022
Q2
$109K Sell
3,547
-8
-0.2% -$233 0.02% 424
2022
Q1
$115K Sell
3,555
-2,298
-39% -$60.2K 0.02% 421
2021
Q4
$162K Buy
5,853
+5,230
+839% +$150K 0.02% 355
2021
Q3
$19K Hold
623
0.01% 762
2021
Q2
$13K Hold
623
﹤0.01% 931
2021
Q1
$13K Hold
623
﹤0.01% 904
2020
Q4
$10K Hold
623
﹤0.01% 899
2020
Q3
$8K Hold
623
﹤0.01% 908
2020
Q2
$4K Hold
623
﹤0.01% 1149
2020
Q1
$3K Buy
+623
New +$5.57K ﹤0.01% 1179

Other funds holding EVH

Lindbrook Capital's EVH Position: Q1 2025 in Review

Lindbrook Capital increased its Evolent Health (EVH) stake by 74% in Q1 2025, buying an estimated $15.3K and bringing the position to 3,558 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Lindbrook Capital first reported a position in EVH in Q1 2020 and has held it in 21 quarters since. The position peaked at $162K in Q4 2021. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Lindbrook Capital held 3,558 shares of Evolent Health worth $33.7K as of Q1 2025.
  • Lindbrook Capital bought 1,516 Evolent Health shares in Q1 2025, an estimated $15.3K.
  • Evolent Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1142 holding.
  • Lindbrook Capital first reported a position in Evolent Health in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Evolent Health position peaked at $162K in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.